Loading company financials…
NYSE · Hospital & Medical Service Plans · CIK 0001156039
$407.50
+3.31% · delayed 15 min
$89.94B market value
What this company does
Elevance Health sells insurance. It took in $199.13B last year, which makes it a very large company. Of every dollar it sells, about 3 cents is left as profit.
Financial health
A mixed picture — some clear strengths and some weaknesses.
From Elevance Health, Inc.'s FY2025 annual filing · share price scored separately
Every check behind the three models, and what each one tests
Measured against FY2024, from the 10-K
Improved: +12.5%
$177.01B to $199.13B
Deteriorated: -5.3%
$5.98B to $5.66B
Deteriorated: -30.3%
$4.55B to
It makes a profit rather than burning through money.
$5.66B earned last year
Day-to-day operations generate real cash, not just accounting profit.
$4.29B cash from operations
Nothing in the filings stands out as a concern.
Filter by minute, hour, day or week
Loading price history…
Expectations
Not from the filings — what other people are betting on, and what the price already assumes.
Measured on and published about a week later — this is a fortnightly snapshot, not a live position.
About 2.4% of this company's shares have been borrowed and sold by people expecting to buy them back cheaper. That is a bet the price falls. Those people can be wrong, and when a heavily shorted share rises they have to buy it back, which pushes it up further.
The essentials
Each answered from the filings, with the numbers behind it.
Yes. It keeps about 3 cents of every dollar of sales as profit, earning $5.66B last year.
What it earns, what it keeps, and what it costs to run — all from the same filing
Whether the dividend is covered by what the business actually earns
It pays out 27 cents of every dollar of profit and keeps the rest, which leaves the payment comfortably covered. It paid out 36% of the cash its operations generated. It has paid in each of the last 12 years.
GoodNext payment expected around , projected from how regularly it has paid before rather than from a date the company has announced.
Figures from the FY2025 annual filing
Last year it earned $5.66B and generated $4.29B of cash from operations.
Insider activity, ownership stakes and what's coming — straight from EDGAR, before any article is written about it
Estimated from how often this has happened before, not a confirmed date.
Not investment advice, and not a signal to act on by itself — a filing says what happened, not why, and insiders trade for ordinary reasons having nothing to do with where they think the company is headed.
Go deeper
Every figure above traces back to one of these filings.
Straight from SEC EDGAR — the original source for every figure above
| Filing | Filed | Covers to |
|---|---|---|
| Quarterly report(10-Q) | 2026-07-15 | 2026-06-30 |
| Major event announcement(8-K) | 2026-07-15 | 2026-07-15 |
Financial figures are from ELV's 10-K for fiscal year 2025 (period ending 2025-12-31), reported under the US GAAP taxonomy. View the source filing.
6 of 9 checks passed
Nine yes-or-no tests of whether this year's finances improved on last year's.
not reported — Not meaningful for banks, insurers and other financial companies. Their balance sheets have no working capital and are leveraged by design, which this model misreads as distress.
Not meaningful for banks, insurers and other financial companies. Their balance sheets have no working capital and are leveraged by design, which this model misreads as distress.
Distance from bankruptcy, from a model fitted on companies that did and did not go bust. It describes a balance sheet's shape today; it does not forecast a failure.
not reported — Not meaningful for banks, insurers and other financial companies. Their balance sheets have no working capital and are leveraged by design, which this model misreads as distress.
Not meaningful for banks, insurers and other financial companies. Their balance sheets have no working capital and are leveraged by design, which this model misreads as distress.
Screens eight accounting ratios for the pattern earnings manipulators tend to leave. A flag is a reason to read the filing closely, never evidence of wrongdoing.
Every figure above comes from the FY2025 filing as filed with the SEC.
Deteriorated: +5.4%
$29.22B to $30.80B
Improved: +14.5%
$8.29B to $9.49B
Improved: -3.0%
227.5M to 220.7M
Changed: -11.1%
$1.26B to $1.12B
2 other measures barely moved. Figures compare the two most recent annual filings — read the latest one. Nothing here reads the management commentary, which is where a company explains its own numbers.
Collected by FINRA from broker-dealers twice a month. It counts positions, not intentions, and some of it is hedging rather than a directional bet against the company.
Nothing in this section is a figure this company reported about itself. These are expectations and positions — what the price implies, what analysts have published, what short sellers are betting, and what large funds held at the last count. WylthIQ reports them; it does not endorse them, does not forecast prices, and takes no view on whether any of them will turn out to be right.
Slowly. Sales grew 12.5% last year.
For every $1 it owes, it owns $1.57 in assets. Banks and insurers always carry high debt — that is how lending works — so this is normal for the industry and not comparable with other sectors.
Around average. Investors pay $15.9 for every $1 of yearly profit.
Not meaningful for banks, insurers and other financial companies. Their balance sheets have no working capital and are leveraged by design, which this model misreads as distress.
At a glance
Reported annual figures
| Major event announcement(8-K) | 2026-06-10 | 2026-06-10 |
| Major event announcement(8-K) | 2026-05-13 | 2026-05-13 |
| Quarterly report(10-Q) | 2026-04-22 | 2026-03-31 |
| Major event announcement(8-K) | 2026-04-22 | 2026-04-22 |
| Shareholder voting information(DEF 14A) | 2026-03-27 | 2026-05-13 |
| Major event announcement(8-K) | 2026-03-10 | 2026-03-10 |
| Major event announcement(8-K) | 2026-03-02 | 2026-03-02 |
| Major event announcement(8-K) | 2026-02-26 | 2026-02-26 |
| Annual report(10-K) | 2026-02-06 | 2025-12-31 |
| Major event announcement(8-K) | 2026-01-28 | 2026-01-28 |
| Major event announcement(8-K) | 2025-12-10 | 2025-12-10 |
| Major event announcement(8-K) | 2025-11-10 | 2025-11-10 |
| Quarterly report(10-Q) | 2025-10-21 | 2025-09-30 |
| Major event announcement(8-K) | 2025-10-21 | 2025-10-21 |
| Major event announcement(8-K) | 2025-09-15 | 2025-09-08 |
| Major event announcement(8-K) | 2025-09-04 | 2025-09-04 |
| Major event announcement(8-K) | 2025-07-28 | 2025-07-28 |
| Quarterly report(10-Q) | 2025-07-17 | 2025-06-30 |
Coverage from the last 30 days
Elevance Health (ELV) Stock Still Looks Undervalued Despite Its 37% Run
Yahoo Finance ·
How Is Elevance Health’s Stock Performance Compared to Other Health Providers?
Yahoo Finance ·
Elevance Health (ELV) Soars as Investors Gain Confidence in Profitability
Yahoo Finance ·
Did AI-Driven Margins and New Behavioral Health Leadership Just Shift Elevance Health's (ELV) Investment Narrative?
Yahoo Finance ·
Elevance Health (ELV) Could Be 11% Undervalued As Carelon Names New Behavioral Health Leader
Yahoo Finance ·
Is Elevance Health (ELV) a Mispriced Opportunity?
Yahoo Finance ·
UnitedHealth vs. Elevance: Which Managed-Care Stock Is a Better Buy?
Yahoo Finance ·
Insurers Have Already Told Wall Street Which Advantage Plans Die on December 31. Members Are the Last to Know, and the Letter Isn’t Due Until October 2.
Yahoo Finance ·
UnitedHealth Stock Rises 39% in 6 Months: Should Investors Still Buy?
Yahoo Finance ·
UnitedHealth Stock Recovered Before Its Margins Did
Yahoo Finance ·
CVS Stock Has Left Its Peers Behind. Or Has It?
Yahoo Finance ·
Centene Stock Roars Back 117% in a Year: Is CNC Still a Buy?
Yahoo Finance ·
Primary sources and further research